Skip to main content
SpringerLink
Log in

Gerinnungsaktivierung bei Reanimation — Gibt es klinische Konsequenzen?

  • Conference paper
Fachübergreifende Aspekte der Hämostaseologie V

  • 26 Accesses

Zusammenfassung

Pro Jahr werden allein in Deutschland bis zu 100.000 Menschen nach einem nicht traumatisch bedingten Herz-Kreislauf-Stillstand prähospital reanimiert. Zwischen 25 und 50% dieser Patienten können initial hämodynamisch stabilisiert werden. Zu einer Krankenhausentlassung kommt es jedoch nur bei etwa 10–15% dieser Patienten [8, 37]. Eine der wesentlichen Ursachen für die hohe intrahospitale Mortalität ist die neurologische bzw. zerebrale Schädigung der Patienten [30,41]. Der individuelle, soziale und volkswirtschaftliche Schaden im Zusammenhang mit der zerebralen Schädigung nach Herz-Kreislauf-Stillstand ist erheblich. Da bisher klinisch keine Therapie zur Verbesserung des neurologischen Outcome nach einem Herz-Kreislauf-Stillstand verfügbar ist [14, 15], fokussieren aktuelle klinische Ansätze auf die therapeutische Anwendung der milden Hypothermie und auf die Thrombolyse während der kardiopulmonalen Reanimation [3,9,11,41].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Arnes A, Wright RL, Kowada M, Thurston JM,Wagno G (1968) Cerebral ischemia II. The no-reflow phenomenon. Am J Pathol 52: 437–453

    Google Scholar 

  2. Bode C, Nordt TK, Runge MS (1994) Thrombolytic therapy in acute myocardial infarction — selected recent developments. Ann Hematol 9: S35–S40

    Article  Google Scholar 

  3. Böttiger BW (1997) Thrombolysis during cardiopulmonary resuscitation. Fibrinolysis 11 (Suppl 2): 93–100

    Google Scholar 

  4. Böttiger BW, Bach A, Bohrer H, Martin E (1993) Die akute Thrombembolie der Lunge. Klinik — Pathophysiologic — Diagnostik — Therapie. Anaesthesist 42: 55–73

    Google Scholar 

  5. Böttiger BW, Bode C, Kern S, Gries A, Gust R, Glätzer R, Bauer H, Mötsch J, Martin E (2001) Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 357: 1583–1585

    Article  PubMed  Google Scholar 

  6. Böttiger BW, Bohrer H, Bach A, Mötsch J, Martin E (1994) Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism. Resuscitation 28: 45–54

    Article  PubMed  Google Scholar 

  7. Böttiger BW, Bohrer H, Böker T, Mötsch J, Aulmann M, Martin E (1996) Platelet factor 4 release in patients undergoing cardiopulmonary resuscitation - can reperfusion be impaired by platelet activation? Acta Anaesthesiol Scand 40: 631–635

    Article  PubMed  Google Scholar 

  8. Böttiger BW, Grabner C, Bauer H, Bode C, Weber T, Mötsch J, Martin E (1999) Long term outcome after out-of-hospital cardiac arrest with physician staffed emergency medical services: the utstein style applied to a midsized urban/suburban area. Heart 82: 674–679

    PubMed  Google Scholar 

  9. Böttiger BW, Martin E (2001) Thrombolytic therapy during cardiopulmonary resuscitation and the role of coagulation activation after cardiac arrest. Curr Opin Crit Care 7: 176–183

    Article  PubMed  Google Scholar 

  10. Böttiger BW, Mötsch J, Bohrer H, Böker T, Aulmann M, Nawroth PP, Martin E (1995) Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation 92: 2572–2578

    PubMed  Google Scholar 

  11. Böttiger BW, Padosch SA, Martin E (2002) Cerebral resuscitation — Pathophysiology, experimental approaches and clinical perspectives. Med Intens Rat 4: 151–158

    Google Scholar 

  12. Böttiger BW, Reim SM, Diezel G (1991) Erfolgreiche Behandlung einer fulminanten Lungenembolie durch hochdosierte Bolusinjektion von Urokinase während der kardiopulmonalen Reanimation. Anästhesiol Intensivmed Notfallmed Schmerzther 26: 29–36

    Article  PubMed  Google Scholar 

  13. Böttiger BW, Reim SM, Diezel G, Bohrer H, Martin E (1994) High-dose bolus injection of urokinase. Use during cardiopulmonary resuscitation for massive pulmonary embolism. Chest 106: 1281–1283

    Google Scholar 

  14. Brain Resuscitation Clinical Trials I Study Group (1986) Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 314: 397–403

    Article  Google Scholar 

  15. Brain Resuscitation Clinical Trials II Study Group (1991) A randomized clinical study of a calcium entry blocker (lidoflazine) in the treatment of comatose survivers of cardiac arrest. N Engl J Med 324: 1225–1231

    Article  Google Scholar 

  16. Crowell JW, Sharpe GP, Lambright RL, Read WL (1955) The mechanism of death after resuscitation following acute circulatory failure. Surgery 38: 696–702

    PubMed  CAS  Google Scholar 

  17. Crowell JW, Smith EE (1956) Effect of fibrinolytic activation on survival and cerebral damage following periods of circulatory arrest. Am J Physiol 186: 283–285

    PubMed  CAS  Google Scholar 

  18. Fischer EG, Ames A, Hedley-White ET, O’Gorman S (1977) Reassessment of cerebral capillary changes in acute global ischemia and their relationship to the, no-reflow phenomenon. Stroke 8: 36–39

    Article  PubMed  CAS  Google Scholar 

  19. Fischer M, Böttiger BW, Popov-Cenic S, Hossmann KA (1996) Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med 22: 1214–1223

    Article  PubMed  CAS  Google Scholar 

  20. Fischer M, Hossmann KA (1995) No-reflow after cardiac arrest. Intensive Care Med 21: 132–141

    Article  PubMed  CAS  Google Scholar 

  21. Gando S, Kameue T, Nanzaki S, Igarashi M, Nakanishi Y (1997) Platelet activation with massive formation of thromboxane A2 during and after cardiopulmonary resuscitation. Intensive Care Med 23: 71–76

    Article  PubMed  CAS  Google Scholar 

  22. Gando S, Kameue T, Nanzaki S, Nakanishi Y (1997) Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Thromb Haemost 77: 278–282

    PubMed  CAS  Google Scholar 

  23. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O (1999) Tissue factor and tissue factor pathway inhibitor levels during and after cardiopulmonary resuscitation. Thromb Res 96: 107–113

    Article  PubMed  CAS  Google Scholar 

  24. Gaszynski W (1974) Research work on blood clotting system during cardiopulmonary resuscitation. Anaesth Resus Inten Therap 2: 303–316

    CAS  Google Scholar 

  25. Gaszynski W (1975) The use of protease inhibitor (Trasylol) and heparin in cardiorespiratory resuscitation. I. Studies of the blood clotting system. Anaesth Resus Inten Therap 3: 125–134

    CAS  Google Scholar 

  26. Ginsberg M, Myers RE (1972) The topography of impaired microvascular perfusion in the primate brain following total circulatory arrest. Neurology 22: 998–1011

    PubMed  CAS  Google Scholar 

  27. Gramann J, Lange-Braun P, Bodemann T, Hochrein H (1988) Einsatzmöglichkeiten der Thrombolyse in der Reanimation. Intensivmed 25: 425–429

    Google Scholar 

  28. Hartveit F, Halleraker B (1970) Intravascular changes in kidneys and lungs after external cardiac massage: A preliminary report. J Pathol 102: 54–58

    Google Scholar 

  29. Hekmatpanah J (1973) Cerebral blood flow dynamics in hypotension and cardiac arrest. Neurology 23: 174–180

    PubMed  CAS  Google Scholar 

  30. Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1: 480–484

    Article  PubMed  CAS  Google Scholar 

  31. Kim YH, Park JH, Hong SH (1999) Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science 284: 647–650

    Article  PubMed  CAS  Google Scholar 

  32. Klefisch FR, Gareis R, Stork T, Möckel M, Danne O (1995) Präklinische Ultima-ratio-Thrombolyse bei therapierefraktärer kardiopulmonaler Reanimation. Intensivmed 32: 155–162

    Google Scholar 

  33. Köhle W, Nechwatel W, Stauch M, Rasche H (1983) Hochdosierte Streptokinasetherapie bei fulminanter Lungenarterienembolie. Verh Dtsch Ges Inn Med 89: 517–519

    Google Scholar 

  34. Latour JG, McKay DG, Parrish MH (1972) Activation of Hageman factor by cardiac arrest. Thromb Diathes Haemorrh 3: 543–553

    Google Scholar 

  35. Lederer W, Lichtenberger C, Pechlaner C, Kroesen G, Baubin M (2001) Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation 50: 71–76

    Article  PubMed  CAS  Google Scholar 

  36. Lin SR, O’Connor MJ, Fischer HW, King A (1978) The effect of combined Dextran and streptokinase on cerebral function and blood flow after cardiac arrest: an experimental study on the dog. Invest Radiol 13: 490–498

    Article  PubMed  CAS  Google Scholar 

  37. Lindner KH, Dirks B, Strohmenger HU, Prengel AW, Lindner IM, Lurie KG (1997) Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 349: 535–537

    Article  PubMed  CAS  Google Scholar 

  38. Newman DH, Greenwald I, Calleway CW (2000) Cardac arrest and the role of thrombolytic agents. Ann Emerg Med 35: 472–480

    PubMed  CAS  Google Scholar 

  39. Ruiz-Bailen M, Aguayo de Hoyos E, Serrano-Corcoles MC, Diaz-Castellanos MA, Ramos-Cuadra JA, Reina-Toral A (2001) Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardiopulmonary resuscitation. Intensive Care Med 27: 1050–1057

    CAS  Google Scholar 

  40. Safar P (1986) Cerebral resuscitation after cardiac arrest: a review. Circulation 74 (Suppl): IV138–IV153

    Google Scholar 

  41. Safar P, Behringer W, Sterz F, Böttiger BW (2002) Cerebral resuscitation potentials for cardiac arrest. Crit Care Med 30 (Suppl): S1–S5

    Article  Google Scholar 

  42. Safar P, Stezoski SW, Nemoto EM (1976) Amelioration of brain damage after 12 minutes cardiac arrest in dogs. Arch Neurol 33: 91–95

    Article  PubMed  CAS  Google Scholar 

  43. Scholz KH, Hilmer T, Schuster S, Wojcik J, Kreuzer H, Tebbe U (1990) Thrombolyse bei reanimierten Patienten mit Lungenembolie. Dtsch Med Wochenschr 115: 930–935

    Article  PubMed  CAS  Google Scholar 

  44. Silfvast T (1991) Cause of death in unsuccessful prehospital resuscitation. J Int Med 229: 331–335

    Article  CAS  Google Scholar 

  45. Spaulding CM, Joly LM, Rosenberg A, Monchi M, Weber SN, Dhainaut JFA, Carli P (1997) Immediate coronary angiography in survivers of out-of-hospital cardiac arrest. N Engl J Med 336: 1629–1633

    Article  PubMed  CAS  Google Scholar 

  46. Stein PD, Henry JW (1995) Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 108: 978–981

    Article  PubMed  CAS  Google Scholar 

  47. Stork T, Bodemann T, Eichstädt H, Hochrein H (1992) Thrombolyse unter Reanimationsbedingungen. Internist 33: 247–251

    PubMed  CAS  Google Scholar 

  48. Tiffany PA, Schultz M, Stueven H (1998) Bolus thrombolytic infusions during CPR for patients with refractory arrest rhythms: Outcome of a case series. Ann Emerg Med 31: 124–126

    Google Scholar 

  49. Westhoff-Bleck M, Gulba DC, Claus G, Rafflenbeul W, Lichtlen PR (1991) Lysetherapie bei protrahierter kardiopulmonaler Reanimation: Nutzen und Komplikationen. Z Kar- diol 80 (Suppl 3): 139

    Google Scholar 

  50. Zipes DP, Wellens HJ (1998) Sudden cardiac death. Circulation 98: 2334–2351

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. B. W. Böttiger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. A. Padosch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Anästhesiologie, Universität Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland

    Eike Martin

  2. Medizinische Klinik I, Universität Heidelberg, Bergheimer Straße 58, 69115, Heidelberg, Deutschland

    Peter Nawroth

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Böttiger, B.W., Padosch, S.A., Martin, E. (2002). Gerinnungsaktivierung bei Reanimation — Gibt es klinische Konsequenzen?. In: Martin, E., Nawroth, P. (eds) Fachübergreifende Aspekte der Hämostaseologie V. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-93394-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93394-3_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-43350-7

  • Online ISBN: 978-3-642-93394-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation